公开(公告)号：US11975046B2

公开(公告)日：2024-05-07

申请号：US18343944

申请日：2023-06-29

Applicant: UCB BIOPHARMA SRL ,  FIVE PRIME THERAPEUTICS, INC.

Inventor： Timothy Scott Johnson ,  Breda Twomey ,  Janine Powers ,  Danielle E. Kellar

IPC: A61K38/21 ,  A61K45/06 ,  A61K47/60 ,  A61P1/00 ,  A61P1/16 ,  A61P13/12 ,  A61P17/00

CPC classification number: A61K38/21 ,  A61K45/06 ,  A61K47/60 ,  A61P1/00 ,  A61P1/16 ,  A61P13/12 ,  A61P17/00

Abstract: The present invention relates to methods for the treatment of fibrosis. The invention discloses new research which demonstrates that interferon-lambda has directly acting anti-fibrotic effects both in vitro and in vivo and may be used to provide effective new therapies for the treatment of multiple types of fibrosis.